NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 703037 | Null | 0.0385613993886001 | -0.12955735 |
NSC 703109 | Null | 0.0385613993886001 | 0.22359218 |
NSC 722854 | 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline | 0.0385613993886001 | 0.12314969 |
NSC 727087 | 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate | 0.0385613993886001 | 0.36591621 |
NSC 728035 | 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di | 0.0385613993886001 | 0.046678185 |
NSC 733504 | Everolimus | 0.0385613993886001 | -0.21394953 |
NSC 736041 | 7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne | 0.0385613993886001 | 0.3186182 |
NSC 405166 | Null | 0.0395466756030202 | 0.085938021 |
NSC 407809 | Card-20(22)-enolide, 3-[(6-O-.beta.-D-glucopyranosyl-.beta.-D-glucopyranosyl)oxy]-14-hydroxy-, (3.beta.,5.alpha.)- (9CI) | 0.0395466756030202 | -2.3314217e-005 |
NSC 665740 | Null | 0.0395466756030202 | 0.078745825 |